Safety and Tolerability of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: Safety Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies

Munjal S.; Lipton R. B.; Brand-Schieber E.; Tepper S. J.; Dodick D. W.

首页> 外文期刊>Headache >Safety and Tolerability of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: Safety Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies

【24h】

Safety and Tolerability of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: Safety Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies

机译：DFN-15（Celecoxib口服溶液，25mg / ml）在急性治疗中的安全性和可耐受性：两期III随机，双盲，安慰剂对照研究的安全结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Headache》 |2019年第1期|共2页
作者
Munjal S.; Lipton R. B.; Brand-Schieber E.; Tepper S. J.; Dodick D. W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and Tolerability of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: Safety Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies [J] . Munjal S., Lipton R. B., Brand-Schieber E., Headache . 2019,第Suppla1期

机译：DFN-15（Celecoxib口服溶液，25mg / ml）在急性治疗中的安全性和可耐受性：两期III随机，双盲，安慰剂对照研究的安全结果
2. Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study [J] . Lipton Richard B., Munjal Sagar, Brand‐Schieber Elimor, Headache . 2020,第1期

机译：DFN-15（Celecoxib口服溶液，25mg / ml）在急性治疗中的疗效，耐受性和安全性，可随机，双盲，安慰剂对照研究
3. Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study [J] . Sagar Munjal, Alix Bennett Neuropsychiatric Disease and Treatment . 2017,第1期

机译：塞来昔布口服液制剂DFN-15在偏头痛成人中的疗效和安全性：一项多中心，随机，安慰剂对照，双盲，交叉研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of DFN-15 an oral liquid formulation of celecoxib in adults with migraine: a multicenter randomized placebo-controlled double-blind crossover study [O] . Sagar Munjal, Alix Bennett 2017

机译：塞来昔布口服液制剂DFN-15在偏头痛成人中的功效和安全性：一项多中心随机安慰剂对照双盲交叉研究
7. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine With or Without Aura [O] . Richard B Lipton, Sagar Munjal, Stewart J Tepper, 2021

机译：塞克西布口服溶液（ELCEXYB）在急性治疗中的多中心，随机，双盲，安慰剂对照研究，伴有或没有光环
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Safety and Tolerability of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: Safety Results from Two Phase III Randomized, Double-blind, Placebo-controlled Studies

著录项

相似文献

相关主题

期刊订阅